Part III: Location of asthma inflammation and the distal airways: clinical implications

References

• Tulic MK, Hamid Q. New insights into the pathophysiology of the small airways in asthma. Clin Chest Med 2006;27:41–52
   PubMed Web of Science ®Google Scholar
• Yanai M, Sekizawa K, Ohrui T, et al. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol 1992;72:1016–23
   PubMed Web of Science ®Google Scholar
• Ohrui T, Sekizawa K, Yanai M, et al. Partitioning of pulmonary responses to inhaled methacholine in subjects with asymptomatic asthma. Am Rev Respir Dis 1992;146:1501–5
   PubMed Web of Science ®Google Scholar
• Wagner EM, Bleecker ER, Permutt S, Liu MC. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 1998;157:447–52
   PubMed Web of Science ®Google Scholar
• Tulic MK, Hamid Q. The role of the distal lung in asthma. Semin Respir Crit Care Med 2002;23:347–59
   PubMed Web of Science ®Google Scholar
• Carroll N, Cooke C, James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 1997;10:292–300
   Google Scholar
• Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323:1033–9
   PubMed Web of Science ®Google Scholar
• Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma J Allergy Clin Immunol 1997;100:44–51
   PubMed Web of Science ®Google Scholar
• Minshall EM, Hogg JC, Hamid QA. Cytokine mRNA expression in asthma is not restricted to the large airways. J Allergy Clin Immunol 1998;101:386–90
   Google Scholar
• Martin RJ. Therapeutic significance of distal airway inflammation in asthma. J Allergy Clin Immunol 2002;109(2 Suppl):S447–60
   PubMed Web of Science ®Google Scholar
• Berman AR, Liu MC, Wagner EM, Proud D. Dissociation of bradykinin-induced plasma exudation and reactivity in the peripheral airways. Am J Respir Crit Care Med 1996;154:418–23
   PubMed Web of Science ®Google Scholar
• Kraft M, Djukanovic R, Wilson S, et al. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996;154:1505–10
   PubMed Web of Science ®Google Scholar
• Martin RJ, Cicutto LC, Smith HR, et al. Airways inflammation in nocturnal asthma. Am Rev Respir Dis 1991;143:351–7
   PubMed Web of Science ®Google Scholar
• Irvin CG, Pak J, Martin RJ. Airway-parenchyma uncoupling in nocturnal asthma. Am J Respir Crit Care Med 2000;161:50–6
   PubMed Web of Science ®Google Scholar
• Kraft M, Pak J, Martin RJ, et al. Distal lung dysfunction at night in nocturnal asthma. Am J Respir Crit Care Med 2001;163:1551–6
   PubMed Web of Science ®Google Scholar
• Wiggs BR, Bosken C, Pare PD, et al. A model of airway narrowing in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1992;145:1251–8
   PubMed Web of Science ®Google Scholar
• Lee YM, Park JS, Hwang JH, et al. High-resolution CT findings in patients with near-fatal asthma: comparison of patients with mild-to-severe asthma and normal control subjects and changes in airway abnormalities following steroid treatment. Chest 2004;126:1840–8
   PubMed Web of Science ®Google Scholar
• Esmailpour N, Hogger P, Rabe KF, et al. Distribution of inhaled fluticasone propionate between human lung tissue and serum in vivo. Eur Respir J 1997;10:1496–9
   PubMed Web of Science ®Google Scholar
• Dolovich MB, Rhem R, Gerrard L, et al. Lung deposition of coarse CFC vs fine HFA pMDI aerosols of beclomethasone dipropionate (BDP) in asthma. Am J Respir Crit Care Med 2000;161:A33
   Google Scholar
• Dolovich MA, MacIntyre NR, Anderson PJ, et al. Consensus statement: aerosols and delivery devices. American Association for Respiratory Care. Respir Care 2000;45:589–96
   PubMedGoogle Scholar
• Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered-dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346–53
   Google Scholar
• Busse WW, Brazinsky S, Jacobson K, et al. Efficacy response of inhaled beclomethasone dipropionate in asthma is proportional to dose and is improved by formulation with a new propellant. J Allergy Clin Immunol 1999;104:1215–22
   PubMed Web of Science ®Google Scholar
• Vanden Burgt JA, Busse WW, Martin RJ, et al. Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma. J Allergy Clin Immunol 2000;106:1209–26
   PubMed Web of Science ®Google Scholar
• Goldin JG, Tashkin DP, Kleerup EC, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999;104:S258–67
   PubMed Web of Science ®Google Scholar
• Richards J, Hirst P, Pitcairn G, et al. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants. J Aerosol Med 2001;14:197–208
   PubMedGoogle Scholar
• Zeidler M, Corren J. Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma. Treat Respir Med 2004;3:35–44
   PubMedGoogle Scholar
• Gross G, VandenBurgt J, Donnell D, et al. New formulation inhaled steroid achieves equivalent peak flow control with half the daily dose in moderate asthmatics (abstract). Eur Respir J 1996;9(Suppl 23):255S
   Google Scholar
• Davies R, Simmons J, Stampone P, Donnell D. Equivalent asthma symptom control of 1500 μg beclomethasone dipropionate (BDP) achieved with 800 μg BDP from fine aerosol solution (abstract). Eur Respir J 1996;9(Suppl 23):254s.
   Google Scholar
• Hauber HP, Gotfried M, Newman K, et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 2003;112:58–63
   PubMed Web of Science ®Google Scholar
• Corren J, Nelson H, Greos LS, et al. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Ann Allergy Asthma Immunol 2001;87:405–11
   PubMed Web of Science ®Google Scholar
• Lipworth BJ. The comparative safety/efficacy ratio of HFABDP. Respir Med 2000;94(Suppl D):S21–6
   Google Scholar
• Fairfax AJ, Donnell D, Song W. CFC-free beclomethasone (BDP) aerosol has improved therapeutic ratio. The Thoracic Society of Australia & New Zealand 1998 Annual Scientific Meeting; Adelaide, 1998:151
   Google Scholar
• Fireman P, Prenner BM, Vincken W, et al. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol. Ann Allergy Asthma Immunol 2001;86:557–65
   PubMed Web of Science ®Google Scholar
• Thompson PJ, Davies RJ, Young WF, et al. Safety of hydrofluoroalkane-134a beclomethasone dipropionate extrafine aerosol. Respir Med 1998;92(Suppl A):33–9
   Google Scholar
• Simons FE. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group. N Engl J Med 1997;337:1659–65
   PubMed Web of Science ®Google Scholar
• Tinkelman DG, Reed CE, Nelson HS, Offord KP. Aerosol beclomethasone dipropionate compared with theophylline as primary treatment of chronic, mild to moderately severe asthma in children. Pediatrics 1993;92:64–77
   PubMed Web of Science ®Google Scholar
• Boguniewicz M, Gillman S. Flunisolide HFA has no effects on growth in children with asthma [poster]. Presented at World Asthma Meeting; Chicago, Illinois, 2001
   Google Scholar
• Gildea TR, Kavuru MS, McCarthy K. Pulmonary function testing: basics of physiology and interpretation. In: The Cleveland Clinic Disease Management Project. Cleveland, Ohio: The Cleveland Clinic Foundation; 2003. Available at: http://www.clevelandclinicmeded.com/diseasemanagement/pulmonary/pft/pft1.htm [Last accessed 24 January 2007]
   Google Scholar
• Little SA, Sproule MW, Cowan MD, et al. High resolution computed tomographic assessment of airway wall thickness in chronic asthma: reproducibility and relationship with lung function and severity. Thorax 2002;57:247–53
   PubMed Web of Science ®Google Scholar
• Goldin JG, Tashkin DP, Kleerup EC, et al. Comparative effects of hydrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 1999;104:S258–67
   PubMed Web of Science ®Google Scholar
• Moller HE, Chen XJ, Saam B, et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002;47:1029–51
   PubMed Web of Science ®Google Scholar
• Sutherland ER, Martin RJ, Bowler RP, et al. Physiologic correlates of distal lung inflammation in asthma. J Allergy Clin Immunol 2004;113:1046–50
   PubMed Web of Science ®Google Scholar
• National Asthma Education and Prevention Program. National Asthma Education and Prevention Program. Expert Panel Report: Guidelines for the Diagnosis and Management of Asthma Update on Selected Topics – 2002. J Allergy Clin Immunol 2002;110(5 Suppl):S141–219
   Google Scholar